NEOVACS news, videos and press releases - Page 2
For more news please use our advanced search feature.
NEOVACS - More news...
NEOVACS - More news...
- NEOVACS : STRENGTHENED ITS INTELLECTUAL PROPERTY IN RUSSIA
- NEOVACS ANNOUNCES POSITIVE RESULTS OF PRECLINICAL STUDY FOR IFNalpha KINOID IN TYPE 1 DIABETES
- ERRATUM: NEOVACS PROVIDES BUSINESS UPDATE AND ANNOUNCES HALF-YEAR 2017 FINANCIAL RESULTS
- NEOVACS PROVIDES BUSINESS UPDATE AND ANNOUNCES HALF-YEAR 2017 FINANCIAL RESULTS
- NEOVACS ANNOUNCES THE CLOSING OF A €6.0 MILLION PRIVATE PLACEMENT WITH U.S. BIOTECHNOLOGY INSTITUTIONAL INVESTORS
- NEOVACS : SUCCESSFULLY RAISES €6.0 MILLION IN PRIVATE PLACEMENT WITH U.S. BIOTECHNOLOGY INSTITUTIONAL INVESTORS
- Neovacs Announces FDA Acceptance of a New IND to Expand in U.S. IFNalpha Kinoid Clinical Development Program in Dermatomyositis
- Neovacs Announces Positive IDSMB Review for Phase IIb Clinical Trial of IFNalpha Kinoid in Lupus
- NEOVACS ANNOUNCES LICENSE AGREEMENT FOR IFNalpha KINOID FOR TREATMENT OF LUPUS IN TURKEY
- NEOVACS ANNOUNCES THE COMPLETION OF PATIENT ENROLLMENT IN PHASE IIB CLINICAL STUDY OF IFNalpha KINOID IN LUPUS
- Neovacs And Lupus Europe Join Voices On World Lupus Day
- Neovacs to present clinical development update on IFNalpha Kinoid in dermatomyosis
- NEOVACS provides corporate update and reports full year 2016 financial results
- Neovacs to present IFNalpha Kinoid technology and its clinical outlooks at upcoming Keystone Symposia Conference
- NEOVACS AND BIOSENSE SIGN OPTION AGREEMENT WORTH UP TO €65 MILLION PLUS ROYALTIES FOR CHINESE DEVELOPMENT AND COMMERCIAL RIGHTS TO IFNalpha KINOID FOR LUPUS AND DERMATOMYOSITIS
- Neovacs issued new broad patent in China for IFNalpha Kinoid
-
Neovacs
- NEOVACS: 2017 Financial Calendar
- Neovacs Reports First Positive Immunogenicity Results for IFNα Kinoid in Model of Type 1 Diabetes
- NEOVACS : REPORTS FIRST POSITIVE IMMUNOGENICITY RESULTS FOR IFN-alpha KINOID IN MODEL OF TYPE 1 DIABETES
- Neovacs to participate in two upcoming investor events in the United States and France
- Neovacs to participate in two upcoming investor events in the United States and France
- Neovacs to collaborate with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal cancer and ovarian cancer
- NEOVACS to collaborate with the SUNNYBROOK RESEARCH INSTITUTE for preclinical development of VEGF Kinoid to treat colorectal cancer and ovarian cancer
- Neovacs obtains FDA “Fast Track” designation for IFNα Kinoid in Lupus (SLE)
- NEOVACS obtains FDA "Fast Track" designation for IFNalpha Kinoid in Lupus (SLE)
- DGAP-News: Neovacs obtains FDA 'Fast Track' designation for IFNα Kinoid in Lupus (SLE)
- Neovacs signs production partnership with 3P Biopharmaceuticals, a leading GMP producer of biological drugs
- Neovacs signs production partnership with 3P Biopharmaceuticals, a leading GMP producer of biological drugs
- DGAP-News: Neovacs signs production partnership with 3P Biopharmaceuticals, a leading GMP producer of biological drugs
